Skip to main content

Table 3 Medications used in patients with Takayasu arteritis with and without tuberculosis

From: Takayasu’s arteritis associated with tuberculosis: a retrospective study

Variables

Tuberculosis

P value

No

Yes

n (%)

n (%)

ASA

23 (46.0)

13 (26.0)

0.522

AHa

   

1

2 (4.0)

5 (10.0)

0.336

2

14 (28.0)

5 (10.0)

3

6 (12.0)

4 (8.0)

>3

2 (4.0)

2 (4.0)

Statins

8 (16.0)

9 (18.0)

0.229

MTXa

   

10–15 mg

6 (12.0)

1 (2.0)

0.246

16–19 mg

7 (14.0)

7 (14.0)

20–25 mg

6 (12.0)

2 (4.0)

MFM

0 (0.0)

1 (2.0)

0.400

AZAa

   

50 mg

0 (0.0)

1 (2.0)

0.189

100 mg

1 (2.0)

2 (4.0)

150 mg

2 (4.0)

0 (0.0)

IFX

0 (0.0)

2 (4.0)

0.155

Prednisonea

   

<10 mg

5 (10.0)

4 (8.0)

0.275

10–20 mg

8 (16.0)

2 (4.0)

>20 mg

0 (0.0)

1 (2.0)

  1. aLikelihood ratio chi-square test
  2. ASA acetyl salicylic acid, AH antihypertensive drugs, MTX methotrexate, MFM mycophenolate mofetil, AZA azathioprine, IFX infliximab